CN213157846U

CN213157846U - L-arabinose capsule

Info

Publication number: CN213157846U
Application number: CN202021134371.6U
Authority: CN
Inventors: 萧舜之; 石国良; 林卫军; 王羽娟; 陈旭
Original assignee: Thomson Biotech Xiamen Pte Ltd
Current assignee: Thomson Biotech Xiamen Pte Ltd
Priority date: 2020-06-18
Filing date: 2020-06-18
Publication date: 2021-05-11
Anticipated expiration: 2030-06-18

Abstract

The utility model discloses an L-arabinose capsule, which comprises two oppositely arranged sub-shells and contents positioned in the inner cavities of the sub-shells; the sub-shell comprises a capsule sub-shell body with an opening at one end and a capsule cover plate; the capsule cover plate is provided with two clamping rings at intervals from inside to outside near the opening end of the capsule shell; the end part of the capsule shell is tightly embedded into the gap between the two clamping rings; the two capsule cover plates are mutually attached, one of the two capsule cover plates is provided with an embedding groove, and the other capsule cover plate is fixed with an embedding strip; the embedded strip is tightly embedded into the embedded groove, and the two sub-shells are detachably mounted together; the two sub-shells of the utility model can be detachably mounted together, so that the crowd with strong oral taking ability can directly take the two sub-shells and the content at one time; the crowd with weaker oral taking ability can be divided into two sub-shells, and the two sub-shells and the content are respectively taken, so that the flexibility is strong, and the taking experience is better.

Description

L-arabinose capsule

Technical Field

The utility model relates to the technical field of capsule structures, specific L-arabinose capsule that says so.

Background

The L-arabinose is not easy to be digested and absorbed by digestive enzymes of human bodies, can provide nutrient substances for intestinal flora after entering large intestine, can proliferate bifidobacterium, and can soften excrement, promote intestinal peristalsis and achieve the effect of treating constipation.

In actual production, the L-arabinose can be prepared into granules and then coated by a capsule shell. The existing capsule is usually prepared according to the oral taking capability of normal adults, the capsule particles are long, when the capsule is taken by people with weak oral taking capability such as old people or children, the capsule is easy to block the throat, the taking experience is poor, and even the health of a user can be damaged.

SUMMERY OF THE UTILITY MODEL

The utility model aims at providing an L-arabinose capsule which is easy to take, two sub-shells can be detachably arranged together, and the contents in the two sub-shells can be directly taken down at one time by people with strong oral taking ability; the crowd with weaker oral taking ability can be split into two sub-shells, and the contents in the two sub-shells are respectively taken down, so that the flexibility is strong, and the taking experience is better.

In order to achieve the above purpose, the utility model adopts the following technical scheme:

the L-arabinose capsule comprises two oppositely arranged sub-shells and contents positioned in the inner cavities of the sub-shells; the sub-shell comprises a capsule sub-shell body with an opening at one end and a capsule cover plate; the capsule cover plate is provided with two clamping rings at intervals from inside to outside near the opening end of the capsule shell; the end part of the capsule shell is tightly embedded into the gap between the two clamping rings; the two capsule cover plates are mutually attached, one of the two capsule cover plates is provided with an embedding groove, and the other capsule cover plate is fixed with an embedding strip; the embedded strip is tightly embedded into the embedded groove, and the two sub-housings are detachably mounted together.

Furthermore, the clamping rings are elastic rings with hollow structures, and the gap between the two clamping rings is smaller than the wall thickness of the capsule shell.

Furthermore, the outer diameters of the capsule shell and the capsule cover plate are the same, and the opening end of the capsule shell is bent inwards and then is tightly embedded into a gap between the two clamping rings.

Furthermore, a ferrule used for improving the connection strength of the sub-shell is tightly sleeved outside the connection position of the sub-shell.

Further, the content is L-arabinose particles.

After the technical scheme is adopted, the utility model discloses following beneficial effect has:

1. the two sub-shells of the L-arabinose capsule of the utility model can be detachably arranged together, so that the crowd with stronger oral taking ability can directly take the two sub-shells and the content at one time; the crowd with weaker oral taking ability can be divided into two sub-shells, and the two sub-shells and the content are respectively taken, so that the flexibility is strong, and the taking experience is better.

2. The utility model discloses L-arabinose capsule, clamping ring are hollow structure's elastic ring, and the clearance between two clamping rings slightly is less than the wall thickness of capsule sub-shell, can be pressed from both sides tightly by two clamping rings behind the clearance between two clamping rings of capsule sub-shell tip embedding, can effectively link together capsule sub-shell and capsule apron.

3. The utility model discloses L-arabinose capsule, capsule sub-shell and capsule apron's external diameter are the same, and the effect is experienced in the taking better.

4. The utility model discloses L-arabinose capsule, lasso can hinder two subshells to take place relative rotation or buckle, can effectively reduce two subshells and take place natural segregation.

Drawings

Fig. 1 is a schematic perspective view of the present invention;

FIG. 2 is a schematic sectional view of the present invention;

FIG. 3 is an enlarged view of a portion A of FIG. 2;

fig. 4 is a schematic sectional structure diagram of the two sub-housings of the present invention when they are not installed together.

The reference numbers in the figures denote:

1. a sub-housing; 10. a capsule shell; 11. a capsule cover plate; 110. caulking grooves; 111. a fillet; 12. a clamping ring; 2. the contents; 3. and (4) looping.

Detailed Description

In order to make the objects, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

Referring to fig. 1 to 4, the L-arabinose capsule comprises two oppositely arranged sub-shells 1 and contents 2 in the inner cavities of the sub-shells 1; the sub-shell 1 comprises a capsule sub-shell body 10 with an opening at one end and a capsule cover plate 11; the capsule cover plate 11 is provided with two clamping rings 12 at intervals from inside to outside near the opening end of the capsule shell 10; the end part of the capsule shell 10 is tightly embedded into the gap between the two clamping rings 12; the two capsule cover plates 11 are mutually attached, wherein one capsule cover plate 11 is provided with a caulking groove 110, and the other capsule cover plate 11 is fixedly provided with a fillet 111; the fillet 111 is tightly inserted into the insertion groove 110, and the two sub-housings 1 are detachably mounted together.

As shown in fig. 2 to 4, the clamping ring 12 is an elastic ring with a hollow structure, and a gap between the two clamping rings 12 is smaller than a wall thickness of the capsule shell 10.

As shown in fig. 2 to 4, the capsule shell 10 and the capsule cover 11 have the same outer diameter, and the open end of the capsule shell 10 is bent inward and then tightly inserted into the gap between the two clamping rings 12.

As shown in fig. 1 to 4, a ferrule 3 for improving the connection strength of the sub-housing 1 is tightly sleeved outside the connection of the sub-housing 1.

As shown in fig. 2 and 3, the content 2 is an L-arabinose particle.

The working principle of the utility model is as follows:

when the L-arabinose capsule of the utility model is used, the two sub-shells 1 can be detachably arranged together, when the capsule is taken by adults and other people with stronger oral taking ability, the two sub-shells 1 do not need to be disassembled, and the two sub-shells 1 and the content 2 can be directly taken at one time; when the capsule is taken by people with weak oral taking ability, such as old people, children and the like, the capsule can be firstly split into the two sub-shells 1, the two sub-shells 1 and the content 2 are respectively taken down, even the capsule cover plate 11 can be opened, and the content 2 is poured out from the capsule sub-shell 10 and then taken, so that the flexibility is strong, and the taking experience is good.

The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention should be covered by the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims

An L-arabinose capsule which is characterized in that: comprises two oppositely arranged sub-shells (1) and contents (2) positioned in the inner cavities of the sub-shells (1); the sub-shell (1) comprises a capsule shell (10) with an opening at one end and a capsule cover plate (11); the capsule cover plate (11) is provided with two clamping rings (12) at intervals from inside to outside near the opening end of the capsule shell (10); the end part of the capsule shell (10) is tightly embedded into a gap between the two clamping rings (12); the two capsule cover plates (11) are mutually attached, a caulking groove (110) is arranged on one capsule cover plate (11), and a fillet (111) is fixed on the other capsule cover plate (11); the embedded strip (111) is tightly embedded into the embedded groove (110), and the two sub-housings (1) are detachably mounted together.
2. The L-arabinose capsule according to claim 1, wherein: the clamping rings (12) are elastic rings with hollow structures, and the gap between the two clamping rings (12) is smaller than the wall thickness of the capsule shell (10).
3. The L-arabinose capsule according to claim 1, wherein: the outer diameters of the capsule shell (10) and the capsule cover plate (11) are the same, and the opening end of the capsule shell (10) is bent inwards and then is tightly embedded into a gap between the two clamping rings (12).
4. The L-arabinose capsule according to claim 3, wherein: and a ferrule (3) for improving the connection strength of the sub-shell (1) is tightly sleeved outside the joint of the sub-shell (1).
5. The L-arabinose capsule according to claim 1, wherein: the content (2) is L-arabinose particles.